Monitor says Celgene cancer drug meets late-stage goals
Filed under: drug treatment news
The study's data safety monitoring board also determined that the pomalidomide drug, given in combination with a low dose of existing treatment dexamethasone, was superior to a high dose of the existing treatment in improving overall survival …
Read more on Reuters
Breast cancer treatment should be reversed
Filed under: drug treatment news
Oncologist Fran Boyle says beginning drug therapy before a sufferer undergoes an operation – which already happens in some parts of Australia – could make it easier for a tumour to be removed. "(The drugs) travel throughout the body killing any cancer …
Read more on The Australian
Third lawsuit filed in Narconon Arrowhead deaths in Oklahoma
Filed under: drug treatment news
The mother of a 32-year-old Tulsa County man who died while undergoing drug rehabilitation treatment at Narconon Arrowhead in Pittsburg County has filed a wrongful-death lawsuit against the corporation. By Randy Ellis | Published: October 25, 2012 …
Read more on NewsOK.com
Celgene Drug improves PFS in Phase III Melanoma Study
Filed under: drug treatment news
Abraxane is in addition approved in the U.S. for the treatment of metastatic breast cancer either after failure of combination chemotherapy, or when relapse occurs within six months of adjuvant chemotherapy . Development is ongoing for pancreatic …
Read more on Genetic Engineering News
Monitor Says Celgene Cancer Drug Meets Late-stage Goals
(Reuters) – An independent safety panel determined that Celgene Corp's experimental cancer drug had met the main goal of a late-stage trial by improving progression-free survival in multiple myeloma patients who have relapsed or not responded to prior treatment, the drugmaker said. The study's data safety monitoring board also determined that the pomalidomide drug, given in combination with a … Read News